Showing posts sorted by relevance for query Iran AND kidney. Sort by date Show all posts
Showing posts sorted by relevance for query Iran AND kidney. Sort by date Show all posts

Tuesday, February 4, 2014

More on the market for kidneys in Iran

Here's an article on the market for kidneys in Iran that I missed when it came out, recently pointed out to me by Mohammad Akbarpour

Kidney International (2012) 82, 627–634; doi:10.1038/ki.2012.219; published online 6 June 2012

The Iranian model of living renal transplantation

Mitra Mahdavi-Mazdeh1
1Iranian Tissue Bank Research & Preparation Center, Tehran University of Medical Sciences, Tehran, Iran
Correspondence: Mitra Mahdavi-Mazdeh, Iranian Tissue Bank Research & Preparation Center, Tehran University of Medical Sciences, Tehran, Iran. E-mail: mmahdavi@sina.tums.ac.ir
Received 6 March 2012; Revised 28 March 2012; Accepted 5 April 2012
Advance online publication 6 June 2012
Top

Abstract

Organ shortage for transplantation remains a worldwide serious problem for kidney patients with end-stage renal failure, and several countries have tried different models to address this issue. Iran has 20 years of experience with one such model that involves the active role of the government and charity foundations. Patients with a desperate demand for a kidney have given rise to a black market of brokers and other forms of organ commercialism only accessible to those with sufficient financial resources. The current Iranian model has enabled most of the Iranian kidney transplant candidates, irrespective of socioeconomic class, to have access to kidney transplantation. The Iranian government has committed a large budget through funding hospital and staff at the Ministry of Health and Medical Education by supporting the brain death donation (BDD) program or redirecting part of the budget of living unrelated renal donation (LURD) to the BDD program. It has been shown that it did not prevent the development and progression of a BDD program. However, the LURD program is characterized by several controversial procedures (e.g., confrontation of donor and recipient at the end of the evaluation procedure along with some financial interactions) that should be ethically reviewed. Operational weaknesses such as the lack of a registration system and long-term follow-up of the donors are identified as the ‘Achilles heel of the model’.

Thursday, December 8, 2016

Opposition to kidney sales in Iran

Afshin Nikzad points me to the following story in Farsi, and provides the translation below. He writes:

"I edit/copy parts of the article from google translate (since it didn't give a great translation) : 
The 78 years old residing in America in an interview with US media said he had been in America for a kidney transplant and doctors had told him he should stay on the waiting list for a kidney transplant from brain death or that of one of his two children. All catch. But he found a third way through his Iranian birth certificate: buying a kidney in Iran. In his interview he talked about the youth in Iran who from the poverty and desperation were lined up to speak to him for selling their kidney.
Doctor, "Ali Husseini,” the head of the Transplantation Society of the Middle East in response to the letter, said: "Buying and selling kidney with strangers is dirty and inhumane and is banned even in countries like India and Pakistan" He also said “among all the thousands seller in the country there is not a single a rich person, all were poor and sold the kidney from poverty and desperation; undoubtedly they  have not donated their kidney.”

Dr. Mohammad Reza Ganji, head of the Iranian Society of Nephrology said “… In the past two years  63% of the transplants have been from brain-dead (that is two thousand and six hundred transplants), and this is statistically significant in the world."

Thursday, September 12, 2013

Advice to those seeking a kidney donor

I occasionally get emails from kidney patients seeking advice about transplantation. Often they are seeking a donor. I don't have much help to offer when I correspond with them, but perhaps the generic form of my response will be useful to others. I'm assuming in what follows that the advice is for a kidney patient who is already registered on the deceased donor waiting list and with an American hospital that does a lot of kidney transplants.

Sometimes people write to me with questions related to kidney exchange, on aspects of which I've written many blog posts. For someone who is looking for a living donor, kidney exchange means that the donor you find needn't be compatible with you, he or she simply needs to be healthy enough to donate a kidney, and willing to donate one so that you get one. One of the several kidney exchange networks can take it from there; it is probably best to work with the one that your transplant center has the easiest working relations with, although you can find the links to the ones I work with the most as you sort through my posts.

When I write to someone who already has a donor I write more than this about kidney exchange, but if you don't have a donor, you need to think about how to get one.

If you are not already registered on the deceased donor waiting list, talk to your docs about getting on the list, since time on the list plays an important role for kidneys.  But the waiting lists are organized by region, and the wait is much longer in some regions of the country than in others. (That's why Steve Jobs, who lived in California, got a liver transplant in Tennessee.)

A new organization that helps people register on the waiting lists of regions where the wait is shorter (even if that isn't where the patient lives) is OrganJet (which I've blogged about here). They are mostly involved in helping arrange transportation (since you have to be able to travel for checkups etc. at the distant hospital at which you are registered in addition to your local hospital). But their website has an app that identifies transplant centers with  shorter waiting times, and that might be a good way to start, since this is a case in which there may be a conflict of interest between you and your local transplant center.

But a living donor is likely better as well as quicker, if you can find one. Here's a link suggesting how to organize a campaign for a living donor:
 Living Kidney Donor Network founded by Harvey Mysel.

There are various kinds of kidney matchmaking sites, like matchingdonors.com, and more specialized sites like http://www.kidneymitzvah.com/ and Renewal.
My impression is that quite a few donors come from faith based organizations, so if you are a member of some kind of congregation, you might let them know of your search for a donor.


*************************
There are other options that I don't recommend, but here's a post with a link to an article by the Harvard Law professor Glenn Cohen that seeks to shed some light on overseas markets for kidneys, some less black than others.

Glenn Cohen on Transplant Tourism: purchasing organ transplants internationally


(There's a legal market for kidneys in Iran, but I believe you have to be an Iranian citizen to participate in it.)

Wednesday, February 20, 2019

Official and unoffical Iranian kidney marketplaces--online prices

The Journal of Urology has published an in-press short paper about an informal website that seems to operate alongside the official Iranian monetary market for kidneys. (Thanks to Jim Brooks for the pointer.)

 Donor Willingness to Accept for Selling a Kidney for Transplantation: Evidence from Iran  by Mehdi Feizi and Tannaz Moeindarbari

"The Iranian model of kidney donation, established in 1988, is a state-funded system of living  renal  transplant  where  the  government  pays  for  all  transplant-related  expenses.  The Iranian Kidney Foundation, IKF hereafter, is in charge to match recipients and compensated donors. On the supply side, each donor registers at the local IKF after conducting preliminary medical  tests.  On  the  demand  side,  any  ESRD  patient  could  enter  the  kidney  waiting  list according to his/her blood type. A renal patient is matched to a donor, basically with the same blood type, based on the first come, first served.

"Both sides could also find each other outside the IKF, say in an online kidney matching website. However, since the transplant is exclusively possible through an official letter from the IKF,  they  have to register there."
***********
The article goes on to analyze prices asked and offered for kidney donation at the online kidney website that they refer to, http://www.koliee.ir/ .  It's in Farsi, but when I ask Google to translate it, their home page looks pretty interesting.  (It seems to offer the opportunity to search for kidneys by price as well as blood type.)

It contains some cautionary sentences:

"If you want to reach your goal without problems on this website, refuse to pay any money before the operation. Also, carry out kidney donation only through the Association for the Protection of Nephrology in your city."

It would be interesting to understand how websites like this interact with the official kidney market.

They also have a list of "our other websites" (again, in translation). The first one deals with surrogacy:





 Rental uterus




 My card




 Kidney donation




 The purse




 Amateur crafts




 Toggle Finder




 Mbti test




 Hello




 Buy and Sell a Loan




 Gnocard

Tuesday, October 13, 2015

The black market for kidneys in South Asia

It sounds like you can buy a kidney in India, and have it transplanted in Sri Lanka. But it isn't clear how large the market is compared to the vast worldwide demand or even to the number of legal kidney  transplants around the world (in the US we have about 17,000) a year). When I say it isn't clear, I mean that the story is based mostly on anecdotal information from market participants...
However I can supply an additional anecdote about social media: almost every morning as I get ready to publish my blog post for the day, I delete spam "comments" on previous posts about kidneys, offering phone numbers to call if you want to sell yours...

Al Jazeera has the story:
Need a kidney? Inside the world’s biggest organ market
The illicit kidney trade in South Asia has exploded as brokers use social media to find donors.

""If you have the money and want it fast, you come here. I will find you a donor and you can go home with a new kidney in a month," Vikas told Al Jazeera, speaking on the condition that his real name not be published.

"According to the World Health Organisation (WHO), South Asia is now the leading transplant tourism hub globally, with India among the top kidney exporters. Each year more than 2,000 Indians sell their kidneys, with many of them going to foreigners.

"This gaping hole between demand and the legal supply of kidneys is being filled by what may be the world's biggest black market for organs, which criss-crosses India, Nepal, Bangladesh, Pakistan, Sri Lanka and Iran.

"However, in recent years, Sri Lanka's capital Colombo has become the new nerve centre of this network, where most transplant operations are carried out. In recent years, Sri Lanka has attracted kidney buyers from as far afield as Israel and the United States.

"This development came after India tightened its rules on organ exchanges in 2008, following the arrest of a "kidney kingpin" running one of the world's largest kidney trafficking rings. Many donors are also taken to Iran, the only country in the world where selling kidneys is legal, though not to foreigners.

"Anurag, one of the top names in brokering circles, told Al Jazeera that many agents in India and Bangladesh were working at the behest of individual doctors or hospitals based in Colombo who offered "complete packages" to foreign recipients, with prices ranging from $53,000 to $122,000.

"It covers everything - hospital bill, doctor's fee, payment to the donor, his travel and accommodation cost, and, of course, broker's commission. This is the best way because it saves everybody time and hassle," Anurag - who also wanted his real name withheld to avoid trouble - told Al Jazeera from Sri Lanka.

"Although the illicit racket has flourished since the 1990s, social media has catapulted the trade into a new dimension. Brokers like Vikas and Aadarsh are openly lurking on dozens of Facebook pages fashioned as kidney and transplant support groups.

HT: Mohammad Akbarpour

Thursday, December 26, 2013

Forthcoming book on the Iranian kidney transplant market

Carolina Academic Press is advertising a forthcoming book,

The Kidney Sellers

A Journey of Discovery in Iran

Their blurb:
Rarely does an adventure story carry such social significance as in this groundbreaking ethnographic research book. Dr. Fry-Revere’s exploration of the medical ethics of compensating organ donors takes us deep inside Iranian culture to provide insight and understanding into how Iran has solved its kidney shortage. The Kidney Sellers: A Journey of Discovery in Iran addresses the question: How it is possible that in Iran there is a waiting list to be a donor, while in the United States hundreds of thousands of people have died­ for lack of a kidney?

Monday, August 22, 2022

Gary Becker's last paper: appropriately, on a monetary market for kidneys (with Julio Elias and Karen Ye, JEBO, 2022)

 Gary Becker, who passed away in 2014, has a new paper, finished by his coauthors Julio Elias and Karen Ye. It recounts how the shortage of transplantable kidneys has only increased as the demand has grown, and the argument for paying donors is as strong as ever.  (In the meantime, the obstacles to that approach haven't vanished.)

The shortage of kidneys for transplant: Altruism, exchanges, opt in vs. opt out, and the market for kidneys*  by Gary S.Becker, Julio Jorge Elias, and Karen J.Ye, Journal of Economic Behavior & Organization, Volume 202, October 2022, Pages 211-226 (Another link to the paper is here, temporarily.)

Abstract: "In 2007 we published a paper on organ transplants that used data from 1990–2005. We proposed a radical solution of paying individuals to donate kidneys, and claimed that this would clean out the waiting list for kidney transplants in a short period of time. In this paper, we revisit the topic, and examine 14 years of additional data to see if anything fundamental has changed. We show that the main altruistic based policies implemented, such as kidney exchanges or opt out systems for organ procurement, have been unable to solve the problem of shortages. Our analysis suggests that, because of the reaction of direct living donors to increases in other sources of donations, the supply curve of kidney transplants is highly inelastic to altruistic policies. In contrast, a market in organs would eliminate organ shortages and thereby eliminate thousands of needless deaths."


Here's the most relevant part of the first footnote:

*"We started working on this paper together with Gary Becker in 2011. In 2012, we presented the paper at the Law and Economics Workshop and the MacLean Center's Seminar Series of the University of Chicago. The paper was unfinished when Becker passed away in May 2014. In this version of the paper, we updated the data and made some additions. The paper preserves all the economic analysis that was developed in the last version that we collaborated with Becker.

"Becker wrote his first article about the organ shortage in 1997, as part of his monthly BusinessWeek Column. The article was entitled How Uncle Sam Could Ease the Organ Shortage. In the article, he “suggest(s) considering the purchase of organs only because other modifications to the present system so far have been grossly inadequate to end the shortage.”

"In the 2000s, Julio Elias collaborated with Becker in a paper that uses the economic approach to analyze the consequences of legalizing the purchase and sale of kidneys for transplants from both deceased and living donors. In 2014, Becker published with Julio Elias a column in the Saturday Essay section of the Wall Street Journal entitled Cash for Kidneys: The Case for a Market for Organs. For Becker, the problem of the organ shortage and finding ways to solve it was a lifelong project. This paper reflects some of his last thoughts on this problem."


Here are their conclusions:

"The current state of the market of kidney transplants is a disaster. Over the last years, the waiting list has grown in over 4000 individuals each year, while transplants have grown by only about 250 per year. The result has been longer and longer queues to receive organs. 4000 patients died each year while waiting 3 and a half years on average for a transplant. According to our estimations, the annual social cost of those who die while waiting for kidney transplants is over $7 billion.

"Neither kidney exchange programs nor opt out systems nor educational campaigns to increase donations from altruistic donors have solved the problem of shortages. The main reason for their mild effects, as we show in this paper, is that the altruistic supply curve of kidney transplants is highly inelastic to these type of policies because of the reaction of direct living donors to increases in other sources of donations.

"The only feasible way to eliminate the large queues in the market for kidney transplants is by significantly increasing the supply of kidneys. The introduction of monetary incentives could increase the supply of organs sufficiently to eliminate the large queues and thereby eliminate thousands of needless deaths, and it would do so without increasing the total cost of kidney transplant surgery by a large percent.

"A market for the purchase and selling of organs would appear strange at first. However, much as the voluntary military today has universal support, the selling of organs would come to be accepted over time. " advantages of accepting payment for organs would eventually become clear, and people will wonder why it took so long for such an ovious and sensible remedy to the organ shortage to be implemented.

***********

Some related earlier posts:

Another take on compensating donors:

Tuesday, August 16, 2022

Kim Krawiec interviews Frank McCormick on the kidney shortage (and how to end it)


Commentary on the  legal monetary market for kidneys in Iran (and how it differs from illegal black markets):

Monday, June 27, 2022

A Forum on Kidneys for Sale in Iran, in Transplant International


The Pontifical Academy of Science says that compensating donors is a crime against humanity:

All my posts on compensation for donors (not just kidney donors) are here.

And here's my 2007 paper on repugnance (that came out in the same issue of JEP as the Becker and Elias paper), and was a first attempt at understanding some of the obstacles that face proposals to compensate donors of kidneys (and other things):


I'm slowly writing a book that will expand on it.

Monday, February 9, 2015

An economist's perspective on transplantation--in Transplantation (the journal)

I have a paper in the latest issue of the journal Transplantation, discussing some approaches to current challenges facing transplantation.

I discuss ways to extend kidney exchange by initiating nondirected donor chains with some deceased donor organs, and by developing  international kidney exchange (along the lines of what Mike Rees calls  reverse transplant tourism). Reducing barriers to participation by transplant centers would also help (e.g removing financial barriers with some kind of standard acquisition fee) and removing barriers for enrolling easy to match pairs, including compatible pairs.  I also discuss ways to increase deceased donor registration, including priorities for donors, and providing other kinds of incentive for donation.

(this link will only get you to the first page; )

Here are some relevant passages from the rest of the paper:

"Extending the reach of kidney exchange

"One way to make kidney exchange accessible to more patients would be to simplify participation. Developing a standard acquisition charge for living donor kidneys  would remove some barriers that arise e.g. from different costs of nephrectomies at hospitals that may need to ship each other kidneys. And matching algorithms could be adjusted to guarantee hospitals that they and their patients won’t lose transplants or sacrifice patient care if they enroll all pairs in exchange (and not just hard-to-match pairs).17 Enrolling easy-to-match pairs, including compatible pairs, can be organized to help those pairs find better matches, and also makes it much easier to find matches for hard-to-match pairs.9, ,  Incentives for transplant centers to enroll their non-directed donors are already being implemented (a chain typically is terminated with a patient on the waiting list of a center that enrolled a non-directed donor).

"Another way to accomplish more transplants through exchange would be to allow some non-directed donor chains to be initiated with deceased donor kidneys1 which, properly organized, could facilitate more transplants and shorten the wait for deceased donor kidneys for all patients.

"Kidney exchange in the developed world could also be extended to patient-donor pairs from countries in which treatment for ESRD is essentially unavailable for large parts of the population.  Such patient-donor pairs could, for example, be invited to come to the U.S. to participate in kidney exchange , financed by the American taxpayer from the savings that result from removing an American from dialysis through receiving a transplant, which are more than sufficient to finance the additional surgeries.  (The bureaucratic obstacles to such exchanges and financial arrangements will be formidable, but the potential to aid both domestic and foreign patients is substantial.)

How else to increase donation?

"There remain many avenues other than kidney exchange through which the shortage of transplantable organs might be reduced.

"In the U.S., the scope for recovering many more transplantable organs from deceased donors seems somewhat limited for most organs, given current technology and recovery rates. But there is suggestive evidence that more frequent opportunities to register as a deceased donor would increase registration, and that the manner in which registration is solicited can influence rates of family consent for donation.

"There is growing consensus that donors should not face financial disincentives from donating, ,  and recent evidence that the costs borne by living donors are substantial enough to reduce donation in recessions. ,  There is consequently great interest in exploring ways to remove disincentives or provide inducements for donation.

"Several novel features of recent Israeli legislation are worth study.  Deceased donation is encouraged by giving registered donors and next-of-kin of deceased donors some priority to receive deceased donor organs. Living kidney donors are also reimbursed 40 days wages, at their own wage rate, to offset the costs of donation. Initial indications are that the new Israeli law is increasing donation.

"The most contentious part of the discussion of how to increase donation concerns cash compensation to donors, particularly living kidney donors. With the prominent exception of Iran, which specifically permits cash payments for kidneys , there does not appear to be a legal market for the purchase and sale of organs for transplant anywhere else, although illegal black markets are widely reported, and occasionally prosecuted.

"However the critical shortage of transplantable organs around the world prompts continual discussion of whether to relax the ban on cash compensation. For example, the March 2014 issue of the Journal of Medical Ethics devoted five articles to the subject, all by philosophers. While this discussion is too important to be left only to philosophers, neither can it be confined to the ongoing debate among transplant professionals, given the public resources devoted to transplantation and the important implications transplantation has for health policy.

"The arguments, pro and con, will already be largely familiar to those who follow this debate.  I will simply try to add some context to the discussion by noting that the ban on organ sales is not unique: other kinds of markets have also been banned in the past, and presently, and laws have changed over time.

"Of course, banning markets does not always end them: black markets for narcotics make clear that outlawing markets is simpler than abolishing them. In the United States, the manufacture and sale of alcoholic beverages was illegal from 1920 to 1933, during which time black markets for alcohol thrived. Less familiarly, an 1824 editorial in The Lancet comments on the black market in which medical schools bought cadavers for dissection from grave robbers, known as “resurrection men,” because the only cadavers that could legally be dissected were from executed murderers.  (The Anatomy Act of 1832 expanded the sources of legal cadavers for dissection in Britain.)

"Let’s call a transaction repugnant if some people want to engage in it, and others, who aren’t materially affected, don’t think they should be allowed to .

"By this definition, sales of kidneys are widely repugnant, as are (or were) the sale of narcotics, alcohol, and cadavers. But note that the ban on kidney sales is different from these other bans, since there is, or was, general disapproval of narcotics, alcohol, and dissection. But there is no similar disapproval of kidney donation and transplantation; it is only sales that are repugnant.

"This turns out not to be too unusual: a transaction that is not otherwise repugnant sometimes becomes so when money is added to the mix. For example, charging interest on loans was largely banned in medieval Europe, although loans were permitted. (The relaxation of that ban has had profound effects on the modern economy.)  Note that repugnance doesn’t only change in one direction—some transactions that used not to be repugnant are widely banned today. Indentured servitude, for example, is no longer legal in the U.S., although it was once a common way of purchasing passage across the Atlantic.41

"Some transactions are banned in some places and not others, e.g. those concerning sale of blood and blood products, and reproductive goods and services such as sperm, eggs, and surrogacy. Legal markets in some places and not others give rise to “fertility tourism,” and many countries that ban payment for blood plasma import plasma products from the U.S., where such payments are legal.

"The repugnance to kidney sales involves concerns about the identity and welfare of potential sellers. The same concerns cause many proposals for allowing some forms of compensation to address the need to avoid exploiting the poor and vulnerable, as existing black markets for kidneys are widely seen to do.  The debate on how to proceed seems likely to focus on removing disincentives to donate and providing incentives that are not seen as leading to coercive or exploitative situations. The debate can be furthered by identifying specific sources of repugnance, and considering how inducements could be structured to avoid them. , ,

"In the meantime, kidney exchange has proved to be a way of bringing some of the benefits of exchange to transplantation without running into the barrier of repugnance. So it seems promising to consider ways of extending its reach, as discussed above."

Saturday, August 8, 2015

Is it time to compensate kidney donors?

Tina Rosenberg in the NY Times thinks it is: It’s Time to Compensate Kidney Donors

"Still, a debate is beginning to emerge. In the United States, some prominent kidney doctors believe we might learn something from Iran. “My journey was from ‘this is all immoral and we shouldn’t think about it’ to the other side,” said Robert Gaston, executive co-director of the Comprehensive Transplant Institute at the University of Alabama at Birmingham, and a recent past president of the American Society of Transplantation, one of two American organizations of transplant doctors. “Iran’s program can’t be termed a universal success. But it is a reasonable approach, a transparent, ethical way to address kidney disease in the population there.”

While no country seems willing to follow Iran into providing monetary incentives for kidney donors, many are starting to remove the financial disincentives that make donating a kidney an activity only for those with disposable income."

Wednesday, September 24, 2014

Kidneys for sale: debates about Iran and it's implications for markets in the West

As I indicated in my post yesterday, the conversation about compensating kidney donors is heating up. Various email correspondents brought to my attention the latest issue of the American Journal of Bioethics, which has a "target" article by Julian Koplin of Monash University and a number of responses and comments. Koplin argues that the experience of kidney sales in Iran should give pause to advocates of (even) regulated markets in the developed world. A number of the commentators argue that the evidence that he cites from Iran is now outdated, among other things. But the conclusions of the commentators are all over the map, from pro to anti and including appeals for allowing some experimentation to gather more evidence, and arguments against 'crossing the Rubicon' by allowing such trials.

I don't know of an ungated URL where you can read this, but of course if you have electronic access to a University library you can likely download it there.

Volume 14, Issue 10, 2014< Prev

The American Journal of Bioethics

ISSN
1526-5161 (Print), 1536-0075 (Online)
Publication Frequency 
12 issues per year
 

Editorial

Nancy S. Jecker
pages 1-6

  • DOI:10.1080/15265161.2014.953858
  • Published online: 17 Sep 2014
  • Citing articles: 0
  • Article Views: 18

Target Article

Julian Koplin
pages 7-18

  • DOI:10.1080/15265161.2014.947041
  • Published online: 17 Sep 2014
  • Citing Articles:
    CrossRef (16) 
  • Article Views: 15
Further Information

Open Peer Commentaries

I. Glenn Cohen
pages 19-21

  • DOI:10.1080/15265161.2014.947787
  • Published online: 17 Sep 2014
  • Citing articles: 0
  • Article Views: 7

James Taylor
pages 21-22

  • DOI:10.1080/15265161.2014.947802
  • Published online: 17 Sep 2014
  • Citing Articles:
    CrossRef (1) 
  • Article Views: 9

Alexander M. CapronGabriel M. Danovitch & Francis L. Delmonico
pages 23-25

  • DOI:10.1080/15265161.2014.947048
  • Published online: 17 Sep 2014
  • Citing articles: 0
  • Article Views: 10

Alberto Giubilini
pages 25-27

  • DOI:10.1080/15265161.2014.947797
  • Published online: 17 Sep 2014
  • Citing Articles:
    CrossRef (1) 
  • Article Views: 11

Erik Malmqvist
pages 27-29

  • DOI:10.1080/15265161.2014.947799
  • Published online: 17 Sep 2014
  • Citing Articles:
    CrossRef (1) 
  • Article Views: 7

Samuel J. Kerstein
pages 29-30

  • DOI:10.1080/15265161.2014.947798
  • Published online: 17 Sep 2014
  • Citing Articles:
    CrossRef (1) 
  • Article Views: 7

Benjamin Hippen
pages 31-33

  • DOI:10.1080/15265161.2014.947047
  • Published online: 17 Sep 2014
  • Citing Articles:
    CrossRef (1) 
  • Article Views: 7

Monir Moniruzzaman
pages 33-35

  • DOI:10.1080/15265161.2014.947801
  • Published online: 17 Sep 2014
  • Citing Articles:
    CrossRef (1) 
  • Article Views: 6

Kiarash Aramesh
pages 35-37

  • DOI:10.1080/15265161.2014.947044
  • Published online: 17 Sep 2014
  • Citing articles: 0
  • Article Views: 8

Sigrid Fry-Revere
pages 37-38

  • DOI:10.1080/15265161.2014.947042
  • Published online: 17 Sep 2014
  • Citing Articles:
    CrossRef (1) 
  • Article Views: 11

Miran Epstein
pages 39-40

  • DOI:10.1080/15265161.2014.947043
  • Published online: 17 Sep 2014
  • Citing Articles:
    CrossRef (1) 
  • Article Views: 6

Atieh PajouhiFarzaneh ZahediZeinab Pajouhi & Bagher Larijani
pages 40-42

  • DOI:10.1080/15265161.2014.947443
  • Published online: 17 Sep 2014
  • Citing articles: 0
  • Article Views: 6

Ryan Tonkens
pages 42-44

  • DOI:10.1080/15265161.2014.947046
  • Published online: 17 Sep 2014
  • Citing articles: 0
  • Article Views: 7

Julie AllardAviva Goldberg & Marie-Chantal Fortin
pages 44-45

  • DOI:10.1080/15265161.2014.947442
  • Published online: 17 Sep 2014
  • Citing articles: 0
  • Article Views: 7

Dominique Martin & Sarah White
pages 46-48

  • DOI:10.1080/15265161.2014.947045
  • Published online: 17 Sep 2014
  • Citing Articles:
    CrossRef (1) 
  • Article Views: 7